CONSOLIDATED STATEMENT OF FINANCIAL POSITION PERIOD ended 31 December 2016 31 December 31 Notes 2016 2016 £000 £000 ASSETS NON CURRENT ASSETS Property, plant and equipment 12 2,914 3,532 Intangible assets 13 719 771 3,633 4,303 CURRENT ASSETS Inventories 15 897 888 Trade and other receivables 16 1,802 1,866 Cash and cash equivalents 292 289 2,988 3,046 TOTAL ASSETS 6,621 7,349 LIABILITIES CURRENT LIABILITIES Borrowings 17 (1,312) (1,422) and other payables 18 (3,604) (3,796) (4,916) (5,218) NON CURRENT LIABILITIES Borrowings 17 (499) (1,376) Deferred tax liability 14 (238) (224) (723) (1,614) TOTAL LIABILITIES (5,639) (6,832) NET CURRENT LIABILITIES (1,928) (2,172) NET ASSETS 982 517 EQUITY ISSUED SHARE CAPITAL ATTRIBUTABLE – TO THE OWNERS OF THE PARENT COMPANY capital 19 1,529 1,492 Share premium account 20 12,722 12,796 Capital redemption reserve 20 1,274 1,274 Share option reserve 20 375 375 Warrant reserve 20 2,236 2,236 Retained deficit 20 (17,228) (17,582) TOTAL EQUITY 982 517 financial statements were approved by the Board of Directors and authorised for issue on 29 June 2017.They were signed on its behalf by: Sergei Kornienko The Notes on pages 25 to 61 form part of these financial statements.
CONSOLIDATED STATEMENT OF FINANCIAL POSITION PERIOD ended 31 December 2016 Notes 31 December 2016 31 2016 £000 £000 ASSETS NON CURRENT ASSETS Property, plant and equipment 12 2,914 3,532 Intangible assets 13 719 771 3,633 4,303 CURRENT ASSETS Inventories 15 897 888 Trade and other receivables 16 1,802 1,866 Cash and cash equivalents 289 292 2,988 3,046 TOTAL ASSETS 6,621 7,349 LIABILITIES CURRENT LIABILITIES Borrowings 17 (1,312) (1,422) and other payables 18 (3,604) (3,796) (4,916) (5,218) NON CURRENT LIABILITIES Borrowings 17 (499) (1,376) Deferred tax liability 14 (224) (238) (723) (1,614) TOTAL LIABILITIES (5,639) (6,832) NET CURRENT LIABILITIES (1,928) (2,172) NET ASSETS 982 517 EQUITY – ISSUED SHARE CAPITAL ATTRIBUTABLE TO THE OWNERS OF THE PARENT COMPANY capital 19 1,529 1,492 Share premium account 20 12,796 12,722 Capital redemption reserve 20 1,274 1,274 Share option reserve 20 375 375 Warrant reserve 20 2,236 2,236 Retained deficit 20 (17,228) (17,582) TOTAL EQUITY 982 517 financial statements were approved by the Board of Directors and authorised for issue on 29 June 2017.They were signed on its behalf by: Sergei Kornienko The Notes on pages 25 to 61 form part of these financial statements.
UVEN%20result%20RNS%20(final%2030Jun)%20(002).docx